Biotech News

Valneva Announces Availability of Documentation for its Annual General Meeting - Valneva

Valneva (VLA)Valneva2026-06-04 12:13 ESTCompany update

Skip to content

Lyon (France), June 4, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company (“the Company”), today announced the availability of documentation for its Annual General Meeting (“the Meeting”) to be held on June 25, 2026 at 2:00 p.m. CEST at the Sofitel Lyon Bellecour Hotel, 20 quai du Docteur Gailleton, 69002 Lyon (France).

To access the full release, please click on the PDF below.

Press Release

We use cookies to improve the functionality and user experience of the website and to analyse the traffic. You can find detailed information in our Privacy Policy . ACCEPT REJECT CHANGE MY PREFERENCES

Open original release

Related news

Valneva

Valneva is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States